Sign In
Get Clay Free →

Suggestions

    Alessia Floerchinger

    M. Sc. Molecular Biosciences, Major Cancer Biology

    Alessia Floerchinger is a PhD student currently affiliated with the German Cancer Research Center (DKFZ) in Heidelberg, Germany. She has been involved in research projects at Witten/Herdecke University, where she has contributed to studies focusing on virotherapy and immunotherapy for cancer treatment.

    Academic Background

    • Education: Alessia completed her Master’s thesis project at Witten/Herdecke University, where she explored innovative approaches in cancer therapy, particularly utilizing oncolytic viruses and bispecific killer engagers.13
    • Research Focus: Her research primarily investigates the efficacy of oncolytic viruses in targeting tumors and enhancing immune responses against cancer cells. A notable publication co-authored by her discusses the use of a vector-encoded bispecific killer engager to harness virus-activated natural killer (NK) cells for anti-tumor effects.12

    Research Contributions

    Alessia's work is part of a broader preclinical research program aimed at developing effective immuno-virotherapies. This includes engineering viruses to selectively target tumors and express therapeutic proteins that enhance the immune system's ability to combat cancer.2 Her contributions are significant in advancing the understanding of how oncolytic viruses can be utilized in clinical settings.

    Professional Experience

    • Current Role: PhD Student at DKFZ since November 2021.
    • Research Project: Engaged in a project at Witten/Herdecke University since May 2021, focusing on cancer virotherapy and related fields.34

    Alessia Floerchinger's work is pivotal in the ongoing efforts to improve cancer treatment methodologies through innovative viral therapies and immune system engagement strategies.

    Highlights

    Feb 10 · nature.com
    A vector-encoded bispecific killer engager to harness virus-activated ...
    A vector-encoded bispecific killer engager to harness virus-activated ...
    A vector-encoded bispecific killer engager to harness virus-activated ...
    Virotherapy - NCT Heidelberg

    Related Questions

    What is Alessia Floerchinger's role in the research project at Witten/Herdecke University?
    How does Alessia Floerchinger contribute to the development of MV-BiKE?
    What are the main findings of Alessia Floerchinger's research on NK cells and cancer treatment?
    What other projects is Alessia Floerchinger involved in at Witten/Herdecke University?
    How does Alessia Floerchinger's work impact the field of immunovirotherapy?
    Alessia Floerchinger
    Alessia Floerchinger, photo 1
    Alessia Floerchinger, photo 2
    Add to my network

    Location

    Heidelberg, Baden-Württemberg, Germany